Microtracer
Showing 1 - 25 of 69
Healthy Subjects Trial in Nottingham (Quizartinib diHCl, 14C-Quizartinib solution for infusion)
Completed
- Healthy Subjects
- Quizartinib dihydrochloride
- 14C-Quizartinib solution for infusion
-
Nottingham, United KingdomQuotient Sciences
Apr 15, 2022
NSCLC Trial (food, fast)
Not yet recruiting
- NSCLC
- food
- fast
- (no location specified)
Jan 24, 2023
Healthy Trial in Groningen (ACT-777991 (SAD), ACT-777991 (MAD), Placebo (SAD))
Completed
- Healthy
- ACT-777991 (SAD)
- +7 more
-
Groningen, NetherlandsQPS Netherlands B.V.
Jun 17, 2022
Sickle Cell Disease Trial in Groningen (GBT021601)
Active, not recruiting
- Sickle Cell Disease
-
Groningen, NetherlandsICON Clinical Research Unit
Jan 30, 2023
Healthy Trial (BI 1015550, BI 1015550 mixed with [C-14]-BI 1015550)
Not yet recruiting
- Healthy
- BI 1015550
- BI 1015550 mixed with [C-14]-BI 1015550
- (no location specified)
Feb 6, 2023
Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)
Not yet recruiting
- Healthy
- BI 1810631 (C-14) formulation 1
- +2 more
- (no location specified)
May 25, 2023
Healthy Volunteers Trial in Nottingham (Oral solution, [14C]BMS-986177 Solution for Infusion, BMS-986177 Spray-dried Dispersion
Completed
- Healthy Volunteers
- Oral solution
- +2 more
-
Nottingham, United KingdomLocal Institution
Nov 11, 2021
Healthy Participants Trial in Groningen (Oral [14C]PF-07081532, Oral PF-07081532 and IV [14C]PF-07081532)
Recruiting
- Healthy Participants
- Oral [14C]PF-07081532
- Oral PF-07081532 and IV [14C]PF-07081532
-
Groningen, NetherlandsPRA Health Sciences
Jan 5, 2023
Type 2 Diabetes, Healthy Subjects Trial in Nottingham (Sotagliflozin (SAR439954), 14C-microtracer, Charcoal)
Completed
- Type 2 Diabetes Mellitus
- Healthy Subjects
- Sotagliflozin (SAR439954)
- +2 more
-
Nottingham, United KingdomInvestigational site number 8260001
Apr 21, 2022
Healthy Trial in Nottingham (GLPG3667 capsule, [14C]-GLPG3667 solution for infusion, [14C]-GLPG3667 capsule)
Completed
- Healthy
- GLPG3667 capsule
- +2 more
-
Nottingham, United KingdomQuotient Sciences Limited
Jun 29, 2022
Breast Cancer, Healthy Volunteers Trial in Nottingham (amcenestrant, [14C]-SAR439859 microtracer, [14C]-SAR439859)
Completed
- Breast Cancer
- Healthy Volunteers
- amcenestrant
- +2 more
-
Nottingham, United KingdomInvestigational Site Number 8260001
Apr 21, 2022
HIV Trial in London (GSK3640254 Oral tablet, [14C]-GSK3640254 intravenous infusion, [14C]-GSK3640254 powder)
Completed
- HIV Infections
- GSK3640254 Oral tablet
- +2 more
-
London, United KingdomGSK Investigational Site
Nov 19, 2021
Idiopathic Pulmonary Fibrosis (IPF) Trial in Manchester (TD-1058, Placebo)
Terminated
- Idiopathic Pulmonary Fibrosis (IPF)
- TD-1058
- Placebo
-
Manchester, United KingdomTheravance Biopharma Investigational Site
Feb 7, 2022
Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men, Hot Flashes Trial in Groningen (Elinzanetant
Completed
- Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men
- Hot Flashes
- Elinzanetant (BAY3427080)
- Esomeprazole
-
Groningen, NetherlandsPRAHealthSciences
Mar 16, 2022
Healthy Volunteers Trial in Baltimore (BIIB122 (DNL151), [14C] BIIB122 ([14C] DNL151))
Completed
- Healthy Volunteers
- BIIB122 (DNL151)
- [14C] BIIB122 ([14C] DNL151)
-
Baltimore, MarylandPharmaron CPC
Nov 9, 2021
Healthy Volunteers Trial in Madison (Acalabrutinib, Microtracer [14C]ACP-196)
Completed
- Healthy Volunteers
- Acalabrutinib
- Microtracer [14C]ACP-196
-
Madison, WisconsinCovance Clinical Research Unit, Inc.
May 21, 2021
Healthy Trial in Groningen (BI 1467335, BI 1467335 (C-14) intravenous solution)
Completed
- Healthy
- BI 1467335
- BI 1467335 (C-14) intravenous solution
-
Groningen, NetherlandsPRA Health Sciences Onderzoekscentrum Martini
Jun 11, 2021
Pulmonary Disease, Chronic Obstructive Trial in London ([14C]-GSK961081 solution for IV infusion, [14C]-GSK961081 oral solution,
Completed
- Pulmonary Disease, Chronic Obstructive
- [14C]-GSK961081 solution for IV infusion
- +2 more
-
London, United KingdomGSK Investigational Site
Sep 28, 2021
Healthy Trial in Nottingham (GLPG3970 film-coated tablet, [14C]GLPG3970 solution for infusion, [14]GLPG3970 oral solution)
Completed
- Healthy
- GLPG3970 film-coated tablet
- +2 more
-
Nottingham, United KingdomQuotient Sciences Ltd
Jul 22, 2021
COPD Trial in Leeds (CHF6001)
Completed
- Chronic Obstructive Pulmonary Disease
-
Leeds, United KingdomCovance - Clinical Research Unit
May 4, 2021
Healthy Trial in Nottingham (GLPG1205 film-coated tablets, [14C]-GLPG1205 solution for infusion, GLPG1205 capsules)
Completed
- Healthy
- GLPG1205 film-coated tablets
- +2 more
-
Nottingham, United KingdomQuotient Sciences
Mar 24, 2021
Healthy Trial in Seoul (LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose)
Completed
- Healthy
- LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 10, 2021
Healthy Trial in Groningen (ACT-1014-6470 (SAD), ACT-1014-6470 (MAD), Placebo (SAD))
Completed
- Healthy
- ACT-1014-6470 (SAD)
- +5 more
-
Groningen, NetherlandsPRA Health Sciences
Aug 11, 2020